The association between normal-range admission potassium levels in Israeli patients with acute coronary syndrome and early and late outcomes

Medicine (United States)

Volumn 95, Issue 23, 2016, Pages

  Shlomai, Gadi ^a,b   Berkovitch, Anat ^a,c   Pinchevski Kadir, Shiran ^a   Bornstein, Gil ^a   Leibowitz, Avshalom ^a   Goldenberg, Ilan ^c   Grossman, Ehud ^a,c  

^a Department of Internal Medicine D   (Israel)

^b Dr Pinchas Borenstein Talpiot Medical Leadership Program 2013 ^*  (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Acute coronary syndrome; Admission serum potassium; Ventricular arrhythmia

Indexed keywords

POTASSIUM; BIOLOGICAL MARKER;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ACUTE KIDNEY FAILURE; ADULT; ARTICLE; BLEEDING; CARDIOGENIC SHOCK; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART ARREST; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART RIGHT VENTRICLE INFARCTION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HIGH RISK PATIENT; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; ISRAELI; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MITRAL VALVE REGURGITATION; MORTALITY RATE; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; AGED; BLOOD; CAUSE OF DEATH; CLINICAL TRIAL; ISRAEL; MULTICENTER STUDY; RISK FACTOR; SURVIVAL RATE; TIME FACTOR; TRENDS;

ACUTE CORONARY SYNDROME; AGED; BIOMARKERS; CAUSE OF DEATH; FEMALE; FOLLOW-UP STUDIES; HUMANS; ISRAEL; MALE; MIDDLE AGED; PATIENT ADMISSION; POTASSIUM; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TIME FACTORS;

EID: 84975464457     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000003778     Document Type: Article

References (27)

1. Al-Quthami AH, Udelson JE. What is the "goal" serum potassium level in acute myocardial infarction? Am J Kidney Dis 2012;60:517-20.
2. El-Sherif N, Turitto G. Electrolyte disorders and arrhythmogenesis. Cardiol J 2011;18:233-45.
3. Macdonald JE, Struthers AD. What is the optimal serum potassium level in cardiovascular patients? J Am Coll Cardiol 2004;43:155-61.
4. Clausen TG, Brocks K, Ibsen H. Hypokalemia and ventricular arrhythmias in acute myocardial infarction. Acta Med Scand 1988;224:531-7.
5. Santulli G, Campanile A, Spinelli L, et al. G protein-coupled receptor kinase 2 in patients with acute myocardial infarction. Am J Cardiol 2011;107:1125-30.
6. Brown MJ. Hypokalemia from beta 2-receptor stimulation by circulating epinephrine. Am J Cardiol 1985;56:3d-9d.
7. Friedensohn A, Faibel HE, Bairey O, et al. Malignant arrhythmias in relation to values of serum potassium in patients with acute myocardial infarction. Int J Cardiol 1991;32:331-8.
8. Hulting J. In-hospital ventricular fibrillation and its relation to serum potassium. Acta Med Scand Suppl 1981;647:109-6.
9. Kafka H, Langevin L, Armstrong PW. Serum magnesium and potassium in acute myocardial infarction. Influence on ventricular arrhythmias. Arch Intern Med 1987;147:465-9.
10. Nordrehaug JE, Johannessen KA, von der Lippe G. Serum potassium concentration as a risk factor of ventricular arrhythmias early in acute myocardial infarction. Circulation 1985;71:645-9.
11. Nordrehaug JE, von der Lippe G. Hypokalaemia and ventricular fibrillation in acute myocardial infarction. Br Heart J 1983;50: 525-9.
12. Peng Y, Huang FY, Liu W, et al. Relation between admission serum potassium levels and long-term mortality in acute coronary syndrome. Intern Emerg Med 2015;10:927-35.
13. Solomon RJ, Cole AG. Importance of potassium in patients with acute myocardial infarction. Acta Med Scand Suppl 1981;647:87-93.
14. Su J, Fu X, Tian Y, et al. Additional predictive value of serum potassium to Thrombolysis In Myocardial Infarction risk score for early malignant ventricular arrhythmias in patients with acute myocardial infarction. Am J Emerg Med 2012;30:1089-4.
15. Goyal A, Spertus JA, Gosch K, et al. Serum potassium levels and mortality in acute myocardial infarction. JAMA 2012;307:157-64.
16. Madias JE, Shah B, Chintalapally G, et al. Admission serum potassium in patients with acute myocardial infarction: its correlates and value as a determinant of in-hospital outcome. Chest 2000;118:904-13.
17. Behar S, Battler A, Porath A, et al. A prospective national survey of management and clinical outcome of acute myocardial infarction in Israel, 2000. Israel Med Assoc J 2003;5:249-54.
18. Choi JS, Kim YA, Kim HY, et al. Relation of serum potassium level to long-term outcomes in patients with acute myocardial infarction. Am J Cardiol 2014;113:1285-90.
19. Bhushan S, Kondo K, Predmore BL, et al. Selective beta2-adrenoreceptor stimulation attenuates myocardial cell death and preserves cardiac function after ischemia-reperfusion injury. Arterioscl Thromb Vasc Biol 2012;32:1865-74.
20. Bernstein D, Fajardo G, Zhao M, et al. Differential cardioprotective/cardiotoxic effects mediated by beta-adrenergic receptor subtypes. Am J Physiol Heart Circulat Physiol 2005;289:H2441-9.
21. Zhu WZ, Zheng M, Koch WJ, et al. Dual modulation of cell survival and cell death by beta(2)-adrenergic signaling in adult mouse cardiac myocytes. Proc Natl Acad Sci USA 2001;98:1607-2.
22. Honda T, Fujimoto K, Miyao Y, et al. Potassium concentration on admissionis an independent risk factor for target lesion revascularization in acute myocardial infarction. Sci World J 2014;2014:946803.
23. Roos M, Ndrepepa G, Baumann M, et al. Serum potassium levels on admission and infarct size in patients with acute myocardial infarction. Clin Chim Acta 2009;409:46-51.
24. Burns RJ, Gibbons RJ, Yi Q, et al. The relationships of left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis. J Am Coll Cardiol 2002;39:30-6.
25. Uribarri J, Oh MS, Carroll HJ. Hyperkalemia in diabetes mellitus. J Diab Complicat 1990;4:3-7.
26. Karet FE. Mechanisms in hyperkalemic renal tubular acidosis. J Am Soc Nephrol 2009;20:251-4.
27. Sousa AG, Cabral JV, El-Feghaly WB, et al. Hyporeninemic hypoaldos-teronism and diabetes mellitus: pathophysiology assumptions, clinical aspects and implications for management. World J Diab 2016;7:101.